Multifocal Electrophysiologic Findings After Intravitreal Bevacizumab(Avastin)Treatment

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

PHASE2/PHASE3

Study Classification

INTERVENTIONAL

Study Start Date

2005-12-31

Study Completion Date

2006-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Purpose: Determine the short-term safety of intravitreal bevacizumab by multifocal electroretinography (mf-ERG).

Methods: 120 eyes with choroidal neovascularization, proliferative diabetic retinopathy and retinal vein occlusion received intravitreal bevacizumab (2.5mg/0.1cc). All patients underwent best corrected visual acuity, fluorescein angiography, optical coherent tomography and mf-ERG before and 1 month after treatment.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy

NCT00423059

Diabetic Retinopathy

COMPLETED NA

Intravitreal Bevacizumab for Inflammatory Neovascular Membranes

NCT00407121

Vogt Koyanagi Harada Disease Serpiginous Choroiditis Multifocal Choroiditis

WITHDRAWN PHASE3

Safety and Effectiveness of Bevacizumab Intravitreal Injections in the Treatment of Macular Edema Secondary to Retinal Vein Occlusion

NCT00970957

Macular Edema Retinal Vein Occlusion

COMPLETED PHASE3

Efficacy and Safety Study of Avastin to Treat Neovascularisation of the Cornea

NCT01501760

Corneal Newvessels

COMPLETED PHASE3

Use of Intravitreal Bevacizumab in Patients With Diffuse Diabetic Macular Edema

NCT00417716

Diabetes Mellitus Type 2 Diabetic Macular Edema

WITHDRAWN PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetic Proliferative Retinopathy Vascular Vein Oclussion Choroidal Neovascularization

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Intravitreal Bevacizumab

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Proliferative diabetic retinopathy, vascular vein oclussion, choroidal neovascularization
* Multifocal electroretinogram before intravitreal bevacizumab and at 1,3, and 6 months after treatment
* Completely studies